Goldman Sachs’s Burcon NutraScience Corporation BRCN Stock Holding History

Goldman Sachs’s Portfolio BRCN Stock Details BRCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,900	Closed	-$10K	–	6799
2022 Q2	$10K	Sell	25,900 -142,500	-85%	-$92.3K	﹤0.01%	6280
2022 Q1	$153K	Buy	168,400 +11,100	+7%	+$10.9K	﹤0.01%	5976
2021 Q4	$189K	Buy	+157,300	New	+$210K	﹤0.01%	5929

Other funds holding BRCN

FFG

Frisch Financial Group Melville, New York $478M AUM 16.28% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Goldman Sachs's BRCN Position: Q3 2022 in Review

Goldman Sachs sold out of Burcon NutraScience Corporation (BRCN) in Q3 2022, closing a stake of 25,900 shares — an estimated $10K sold.

Goldman Sachs first reported a position in BRCN in Q4 2021 and held it in 3 quarters. The position peaked at $189K in Q4 2021. 2 funds tracked by Wall St. Rank hold BRCN as of Q3 2022.

Goldman Sachs reported no remaining Burcon NutraScience Corporation position as of Q3 2022 after selling out during the quarter.
Goldman Sachs sold 25,900 Burcon NutraScience Corporation shares in Q3 2022, an estimated $10K.
Goldman Sachs first reported a position in Burcon NutraScience Corporation in Q4 2021 and held it in 3 quarters.
Goldman Sachs's Burcon NutraScience Corporation position peaked at $189K in Q4 2021.
2 funds tracked by Wall St. Rank held Burcon NutraScience Corporation as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.